Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ascendis Pharma A (ASND) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for Ascendis Pharma A (ASND) over the last 14 years, with Q4 2025 value amounting to $4377.2.

  • Ascendis Pharma A's Shares Outstanding (Diluted Average) fell 3727.07% to $4377.2 in Q4 2025 from the same period last year, while for Dec 2025 it was $4377.2, marking a year-over-year decrease of 3727.07%. This contributed to the annual value of $4249.2 for FY2025, which is 3910.54% down from last year.
  • Per Ascendis Pharma A's latest filing, its Shares Outstanding (Diluted Average) stood at $4377.2 for Q4 2025, which was down 3727.07% from $3764.4 recorded in Q3 2025.
  • Ascendis Pharma A's Shares Outstanding (Diluted Average)'s 5-year high stood at $8.1 million during Q4 2021, with a 5-year trough of $1662.0 in Q1 2025.
  • For the 5-year period, Ascendis Pharma A's Shares Outstanding (Diluted Average) averaged around $948444.0, with its median value being $4520.9 (2023).
  • Per our database at Business Quant, Ascendis Pharma A's Shares Outstanding (Diluted Average) tumbled by 9986.86% in 2023 and then soared by 1757.07% in 2024.
  • Over the past 5 years, Ascendis Pharma A's Shares Outstanding (Diluted Average) (Quarter) stood at $8.1 million in 2021, then decreased by 13.6% to $7.0 million in 2022, then plummeted by 99.87% to $9199.3 in 2023, then dropped by 24.15% to $6977.9 in 2024, then crashed by 37.27% to $4377.2 in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $4377.2 for Q4 2025, versus $3764.4 for Q3 2025 and $2513.0 for Q2 2025.